HROW — Harrow Health Inc · rev $114.9M

Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.

Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.

Use this HROW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HROW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HROW SEC filings page. Lician reads the product cache first so this HTML stays unique to Harrow Health Inc even when a live quote feed is slow.